Levosalbutamol Respiratory Solution 0.31

Leval 0.31 is a respiratory solution containing levosalbutamol, a selective beta-2 adrenergic agonist used for the treatment of bronchospasm associated with conditions such as asthma and chronic obstructive pulmonary disease (COPD). Levosalbutamol is the active enantiomer of salbutamol, which means it specifically targets beta-2 receptors in the lungs, leading to smooth muscle relaxation and subsequent bronchodilation. This action helps to quickly open the airways, making breathing easier and providing relief from symptoms such as wheezing, shortness of breath, and chest tightness.

Administered via a nebulizer, Leval 0.31 is particularly effective for patients who may have difficulty using traditional inhalers, including young children, elderly individuals, or those experiencing severe respiratory distress. The nebulizer converts the solution into a fine mist, ensuring that the medication reaches deep into the lungs for optimal absorption and rapid onset of action.

Leval 0.31 is typically used as needed to relieve acute bronchospasm or as part of a maintenance regimen to prevent symptoms triggered by exercise or environmental factors. Its rapid action and effectiveness in opening airways make it an essential medication for managing acute episodes of respiratory distress.